
{
  "Company Overview": {
    "Name": "Saakshi Medtech & Panels Ltd",
    "Sector": "Capital Goods - Electrical Equipment",
    "Industry": "Electric Equipment",
    "Business Description": "Incorporated in 2009, Saakshi Medtech & Panels Ltd deals in Electrical Control Panels, Medical X-Ray Systems, Fabrication & Wire Harness. It caters to OEM’s in various segments like Oil & Gas, Aviation, Renewables, Healthcare, Locomotives etc.",
    "Market Position": "Information not explicitly available in provided HTML" 
  },
  "Financial Metrics": {
    "Market Cap": "₹ 389 Cr.",
    "Current Price": "₹ 220",
    "High/Low": "₹ 369 / ₹ 176",
    "Stock P/E": "42.2",
    "Book Value": "₹ 54.8",
    "Dividend Yield": "0.00%",
    "ROCE": "19.2%",
    "ROE": "16.7%",
    "Face Value": "₹ 10.0",
    "Debt-to-Equity Ratio": "Information not explicitly available in provided HTML" 
  },
  "Performance Trends": {
    "Quarterly Results": {
      "Sales": {
        "Sep 2023": "61 Cr",
        "Mar 2024": "61 Cr",
        "Sep 2024": "44 Cr"
      },
      "Expenses": {
        "Sep 2023": "52 Cr",
        "Mar 2024": "51 Cr",
        "Sep 2024": "38 Cr"
      },
      "Operating Profit": {
        "Sep 2023": "10 Cr",
        "Mar 2024": "10 Cr",
        "Sep 2024": "6 Cr"
      },
      "OPM %": {
        "Sep 2023": "16%",
        "Mar 2024": "16%",
        "Sep 2024": "15%"
      },
      "Net Profit": {
        "Sep 2023": "6 Cr",
        "Mar 2024": "6 Cr",
        "Sep 2024": "3 Cr"
      },
      "EPS in Rs": {
        "Sep 2023": "3.27",
        "Mar 2024": "1.95"
      }
    },
    "Annual Results": {
      "Sales": {
        "Mar 2020": "61 Cr",
        "Mar 2021": "60 Cr",
        "Mar 2022": "92 Cr",
        "Mar 2023": "143 Cr",
        "Mar 2024": "143 Cr",
        "TTM": "105 Cr"
      },
      "Expenses": {
        "Mar 2020": "50 Cr",
        "Mar 2021": "54 Cr",
        "Mar 2022": "76 Cr",
        "Mar 2023": "123 Cr",
        "Mar 2024": "123 Cr",
        "TTM": "89 Cr"
      },
      "Operating Profit": {
        "Mar 2020": "11 Cr",
        "Mar 2021": "6 Cr",
        "Mar 2022": "16 Cr",
        "Mar 2023": "21 Cr",
        "Mar 2024": "20 Cr",
        "TTM": "16 Cr"
      },
      "Net Profit": {
        "Mar 2020": "6 Cr",
        "Mar 2021": "2 Cr",
        "Mar 2022": "9 Cr",
        "Mar 2023": "12 Cr",
        "Mar 2024": "11 Cr",
        "TTM": "9 Cr"
      },
      "EPS in Rs": {
        "Mar 2020": "6.41",
        "Mar 2021": "5.22"
      }
    },
    "Balance Sheet Highlights": {
      "Equity Capital": {
        "Mar 2020": "3 Cr",
        "Mar 2021": "3 Cr",
        "Mar 2022": "3 Cr",
        "Mar 2023": "3 Cr",
        "Mar 2024": "18 Cr",
        "Sep 2024": "18 Cr"
      },
      "Reserves": {
        "Mar 2020": "15 Cr",
        "Mar 2021": "18 Cr",
        "Mar 2022": "27 Cr",
        "Mar 2023": "40 Cr",
        "Mar 2024": "76 Cr",
        "Sep 2024": "79 Cr"
      },
      "Borrowings": {
        "Mar 2020": "19 Cr",
        "Mar 2021": "22 Cr",
        "Mar 2022": "16 Cr",
        "Mar 2023": "20 Cr",
        "Mar 2024": "18 Cr",
        "Sep 2024": "14 Cr"
      }
    },
    "Cash Flow Summaries": {
      "Cash from Operating Activity": {
        "Mar 2020": "11 Cr",
        "Mar 2021": "0 Cr",
        "Mar 2022": "11 Cr",
        "Mar 2023": "11 Cr",
        "Mar 2024": "7 Cr"
      },
      "Net Cash Flow": {
        "Mar 2020": "2 Cr",
        "Mar 2021": "1 Cr",
        "Mar 2022": "-1 Cr",
        "Mar 2023": "2 Cr",
        "Mar 2024": "12 Cr"
      }
    }
  },
  "Ratios": {
    "Growth Ratios": {
      "Compounded Sales Growth": {
        "3 Years": "34%",
        "TTM": "-19%"
      },
      "Compounded Profit Growth": {
        "3 Years": "76%",
        "TTM": "-27%"
      },
      "Stock Price CAGR": {
        "1 Year": "0%"
      }
    },
    "Liquidity Ratios": {
      "Debtor Days": {
        "Mar 2020": "62",
        "Mar 2021": "90",
        "Mar 2022": "70",
        "Mar 2023": "58",
        "Mar 2024": "44"
      },
      "Inventory Days": {
        "Mar 2020": "74",
        "Mar 2021": "95",
        "Mar 2022": "81",
        "Mar 2023": "109",
        "Mar 2024": "101"
      },
      "Days Payable": {
        "Mar 2020": "73",
        "Mar 2021": "97",
        "Mar 2022": "83",
        "Mar 2023": "93",
        "Mar 2024": "43"
      },
      "Cash Conversion Cycle": {
        "Mar 2020": "63",
        "Mar 2021": "88",
        "Mar 2022": "67",
        "Mar 2023": "74",
        "Mar 2024": "102"
      },
      "Working Capital Days": {
        "Mar 2020": "62",
        "Mar 2021": "93",
        "Mar 2022": "66",
        "Mar 2023": "63",
        "Mar 2024": "83"
      }
    },
    "Profitability Ratios": {
      "ROCE %": {
        "Mar 2020": "12%",
        "Mar 2021": "32%",
        "Mar 2022": "33%",
        "Mar 2023": "19%"
      },
      "Return on Equity": {
        "3 Years": "26%",
        "Last Year": "17%"
      },
      "OPM %": {
        "Mar 2020": "18%",
        "Mar 2021": "10%",
        "Mar 2022": "17%",
        "Mar 2023": "14%",
        "Mar 2024": "14%",
        "TTM": "16%"
      }
    },
    "Valuation Ratios": {
      "Price to Book": "Information not explicitly available but can be calculated from available data"
    }
  },
  "Peer Comparison": {
    "Peers": [
      {"Name": "Siemens", "CMP": "6868.90", "P/E": "90.04", "Mar Cap": "244615.61", "Div Yld": "0.15", "NP Qtr": "831.20", "Qtr Profit Var": "45.41", "Sales Qtr": "6461.10", "Qtr Sales Var": "11.25", "ROCE": "25.59"},
      {"Name": "A B B", "CMP": "6921.25", "P/E": "86.89", "Mar Cap": "146667.08", "Div Yld": "0.34", "NP Qtr": "440.45", "Qtr Profit Var": "21.68", "Sales Qtr": "2912.16", "Qtr Sales Var": "5.16", "ROCE": "30.69"},
      {"Name": "CG Power & Ind", "CMP": "730.05", "P/E": "124.61", "Mar Cap": "111592.02", "Div Yld": "0.18", "NP Qtr": "219.63", "Qtr Profit Var": "-1.77", "Sales Qtr": "2412.69", "Qtr Sales Var": "20.54", "ROCE": "46.63"},
      {"Name": "Suzlon Energy", "CMP": "64.13", "P/E": "88.00", "Mar Cap": "86810.83", "Div Yld": "0.00", "NP Qtr": "200.60", "Qtr Profit Var": "45.89", "Sales Qtr": "2103.38", "Qtr Sales Var": "47.98", "ROCE": "24.93"},
      {"Name": "Waaree Energies", "CMP": "2879.35", "P/E": "83.70", "Mar Cap": "82718.89", "Div Yld": "0.00", "NP Qtr": "375.66", "Qtr Profit Var": "14.78", "Sales Qtr": "3574.38", "Qtr Sales Var": "1.05", "ROCE": "43.63"},
      {"Name": "B H E L", "CMP": "235.30", "P/E": "184.25", "Mar Cap": "81932.95", "Div Yld": "0.11", "NP Qtr": "106.15", "Qtr Profit Var": "268.47", "Sales Qtr": "6584.10", "Qtr Sales Var": "28.46", "ROCE": "3.37"},
      {"Name": "Premier Energies", "CMP": "1296.40", "P/E": "253.01", "Mar Cap": "58438.39", "Div Yld": "0.00", "NP Qtr": "205.95", "Qtr Profit Var": "289.61", "Sales Qtr": "1527.22", "Qtr Sales Var": "120.16", "ROCE": "25.23"}
    ],
    "Median": {
      "CMP": "525.73",
      "P/E": "69.63",
      "Mar Cap": "1616.72",
      "Div Yld": "0.0",
      "NP Qtr": "8.31",
      "Qtr Profit Var": "34.14",
      "Sales Qtr": "127.8",
      "Qtr Sales Var": "21.98",
      "ROCE": "19.48"
    }
  },
  "Other Insights": {
    "Pros": [
      "Company has reduced debt.",
      "Company has a good return on equity (ROE) track record: 3 Years ROE 25.6%",
      "Debtor days have improved from 57.4 to 44.2 days."
    ],
    "Cons": [
      "Though the company is reporting repeated profits, it is not paying out dividend"
    ],
    "Disclaimer": "The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis." ,
    "Notes on Shareholding Pattern": "* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards. Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes. Click on the line-items to see the names of individual entities."
  }
}
